Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Clinical trial NCT04048564 · COMPLETED
Trial details
- NCT number
- NCT04048564
- Sponsor
- Incyte BioSciences France
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-02-23
- Primary completion
- 2022-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.